Chengda Pharmaceuticals Co., Ltd. (301201)
XSHE XSHE Primary Summary
Chengda Pharmaceuticals Co., Ltd. (301201) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Chengda Pharmaceuticals Co., Ltd. ever had a stock split?
Chengda Pharmaceuticals Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Gang Lu CEO | XSHE Exchange | CNE100005766 ISIN |
| CN Country | 659 Employees | - Last Dividend | 7 Jul 2023 Last Split | - IPO Date |
Overview
ChengDa Pharmaceuticals Co., Ltd. is a prominent player in the pharmaceutical sector, with a comprehensive focus on the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and additives for food and feed. The company's operations span both the domestic market in China and various international landscapes, reflecting its global outreach and reputation. Founded in 1980 and headquartered in Jiaxing, China, ChengDa Pharmaceuticals has built a legacy of innovation and excellence in the pharmaceutical industry over the past four decades. Its commitment to quality and the extensive range of products it offers cater to diverse medical needs, positioning the company as a key supplier in the pharmaceutical value chain.
Products and Services
ChengDa Pharmaceuticals Co., Ltd. provides a wide array of products and services that cater to the healthcare and chemical sectors, including:
- APIs (Active Pharmaceutical Ingredients): These are the essential components of any drug that produce the intended effects. ChengDa Pharmaceuticals specializes in the development and manufacture of high-quality APIs that are crucial for creating effective pharmaceutical products.
- Bulk Drugs: The company produces bulk drugs that are used in a variety of therapeutic areas. This includes medicines for:
- Urogenital Disorders: Medications focused on diseases affecting the urinary and genital tracts.
- Musculoskeletal System: Drugs intended for the treatment of conditions affecting muscles and bones.
- Antineoplastic and Immunomodulators: Medications designed to treat cancer and modulate the immune system.
- Drug Intermediates: These are the compounds that are used in the process of creating APIs. ChengDa Pharmaceuticals offers intermediates for drugs that cater to:
- Blood and Hematopoietic Organs: Intermediates for medicines that affect blood and its production.
- Digestive Tract and Metabolism: Compounds used in treatments for the digestive system and metabolic disorders.
- Nervous System: Ingredients for medications aimed at treating nervous system disorders.
